TickerFacts.

Nephros Inc (NEPH): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2013-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.34M
Year ended 2025-12-31
$1.45M
Trailing 12 months to 2026-06-30
+2.2%
3-year compound annual growth
$3.09M2010-12-31: $362.0K2011-12-31: $451.0K2012-12-31: $632.0K2013-12-31: $867.0K2014-12-31: $781.0K2015-12-31: $826.0K2016-12-31: $1.08M2017-12-31: $1.00M2018-12-31: $1.54M2019-12-31: $3.09M2020-12-31: $2.76M2021-12-31: $1.50M2022-12-31: $1.25M2023-12-31: $873.0K2024-12-31: $906.0K2025-12-31: $1.34M$1.34M
2010-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$1.34M+47.8%2026-03-12, From 2025-01-01
2024-12-31$906.0K+3.8%2026-03-12, From 2024-01-01
2023-12-31$873.0K-30.4%2025-03-24, From 2023-01-01
2022-12-31$1.25M-16.2%2024-03-15, From 2022-01-01
2021-12-31$1.50Mn/c2023-03-23, From 2021-01-01
2020-12-31$2.76M-10.7%2022-03-03, From 2020-01-01
2019-12-31$3.09M+100.8%2021-03-01, From 2019-01-01
2018-12-31$1.54M+53.6%2020-02-27, From 2018-01-01
2017-12-31$1.00M-7.1%2019-03-12, From 2017-01-01
2016-12-31$1.08M+30.6%2018-02-26, From 2016-01-01
2015-12-31$826.0K+5.8%2017-03-20, From 2015-01-01
2014-12-31$781.0K-9.9%2016-03-30, From 2014-01-01
2013-12-31$867.0Kn/c2015-04-15, From 2013-01-01
2012-12-31$632.0K+40.1%2014-03-28, From 2012-01-01
2011-12-31$451.0K+24.6%2013-03-04, From 2011-01-01
2010-12-31$362.0Kn/a2012-03-22, From 2010-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Nephros Inc (NEPH)2025-12-31$1.34M+47.8%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$2.27M+25.2%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$100.0K0.0%
Profound Medical Corp. (PROF)2025-12-31$20.60M+21.4%
Biotricity Inc. (BTCY)2026-03-31$2.76M+28.2%
DarioHealth Corp. (DRIO)2025-12-31$13.79M-43.0%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$20.13M+226.0%
Allurion Technologies, Inc. (ALUR)2025-12-31$7.57M-56.4%
Sensus Healthcare, Inc. (SRTS)2025-12-31$7.78M+84.5%

Compare NEPH, SNOA, VVOS, PROF side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗